Menu
Find a Doctor

What is SpaceOAR Hydrogel?

Find Out How SpaceOAR
Can Help

SpaceOAR Clinical Studies

Fewer Complications

Frequently Asked Questions

SPACEOAR® spotlight


augmenix_logo_large_CMYKFunding Will Enable Accelerated Sales Growth and Development of Next Generation Products

 

WALTHAM, Mass.–(BUSINESS WIRE)–Augmenix, Inc., a privately held company developing minimally invasive hydrogel products to improve outcomes following cancer radiotherapy, today announced it secured $6 million in series E funding from existing investors. (Read More)

See More SpaceOAR Media

Recent Posts

See All Posts
A new study has shed light on the link between a decreased risk of prostate cancer mortality and tree nut consumption.

New study finds link between nut consumption and prostate cancer

Consuming more tree nuts may help lower the risk of prostate cancer mortality in men.

Separating fact from fiction when it comes to prostate cancer is not always easy.

Top myths surrounding prostate cancer

Many of the most common misconceptions about prostate cancer are easily debunked.

SBRT for prostate cancer requires far fewer treatments that standard radiation methods.

Preparing for SBRT: What you need to know

SBRT treatment requires far fewer treatment sessions than tradiational radiation therapies.

Upcoming Events

See All Events
Sep 9

Augmenix’s vision is to improve the lives of patients receiving radiation therapy.

Learn more about Augmenix